Assenagon Asset Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.23M | Sell |
|
|||||
|
2025
Q2 | $16.3M | Buy |
|
|||||
|
2025
Q1 | $7.41M | Sell |
|
|||||
|
2024
Q4 | $9.24M | Sell |
|
|||||
|
2024
Q3 | $19.2M | Sell |
|
|||||
|
2024
Q2 | $18.2M | Buy |
|
|||||
|
2024
Q1 | $1.69M | Sell |
|
|||||
|
2023
Q4 | $2.28M | Hold |
|
|||||
|
2023
Q3 | $2.27M | Sell |
|
|||||
|
2023
Q2 | $16.9M | Sell |
|
|||||
|
2023
Q1 | $37.3M | Buy |
|
|||||
|
2022
Q4 | $18.2M | Sell |
|
|||||
|
2022
Q3 | $22.8M | Sell |
|
|||||
|
2022
Q2 | $23M | Buy |
|
|||||
|
2022
Q1 | $8.02M | Buy |
|
|||||
|
2021
Q4 | $6.07M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $6.64M | Buy |
|
|||||
|
2020
Q2 | $3.35M | Sell |
|
|||||
|
2020
Q1 | $6.28M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $494K | Buy |
|